Oric Pharmaceuticals Inc
NASDAQ:ORIC

Watchlist Manager
Oric Pharmaceuticals Inc Logo
Oric Pharmaceuticals Inc
NASDAQ:ORIC
Watchlist
Price: 8.43 USD 1.93% Market Closed
Market Cap: 821m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of ORIC.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ORIC Intrinsic Value
Not Available
Base Case Scenario
Compare ORIC to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ORIC?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Oric Pharmaceuticals Inc

Current Assets 295.6m
Cash & Short-Term Investments 287.1m
Other Current Assets 8.5m
Non-Current Assets 135.6m
Long-Term Investments 125.9m
PP&E 2.6m
Other Non-Current Assets 7.1m
Current Liabilities 20.2m
Accounts Payable 2.9m
Accrued Liabilities 17.3m
Non-Current Liabilities 4.1m
Other Non-Current Liabilities 4.1m
Efficiency

Free Cash Flow Analysis
Oric Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Oric Pharmaceuticals Inc

Revenue
0 USD
Operating Expenses
-148m USD
Operating Income
-148m USD
Other Expenses
12.8m USD
Net Income
-135.3m USD
Fundamental Scores

ORIC Profitability Score
Profitability Due Diligence

Oric Pharmaceuticals Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Declining ROE
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
28/100
Profitability
Score

Oric Pharmaceuticals Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

ORIC Solvency Score
Solvency Due Diligence

Oric Pharmaceuticals Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Oric Pharmaceuticals Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ORIC Price Targets Summary
Oric Pharmaceuticals Inc

Wall Street analysts forecast ORIC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ORIC is 21.34 USD with a low forecast of 15.15 USD and a high forecast of 26.25 USD.

Lowest
Price Target
15.15 USD
80% Upside
Average
Price Target
21.34 USD
153% Upside
Highest
Price Target
26.25 USD
211% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Oric Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ORIC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ORIC Insider Trading
Buy and sell transactions by insiders

ORIC News